All Eights
All Eights is a Singapore-headquartered distributor of in-vitro clinical diagnostic, analytical science, and laboratory equipment products, serving clinical laboratories, hospitals, and research centers across Singapore, Malaysia, and Indonesia through 40+ international brand partnerships since 1983.
- Company typePrivate
- Founded1983
- HeadquartersSingapore, Singapore
- Headcount11–50
- GTM typeB2B
- OfferingServices
What All Eights does
All Eights (Singapore) Pte Ltd is a Singapore-headquartered specialist distributor of in-vitro clinical diagnostic, analytical science, and laboratory equipment products, founded in 1983 by Mr. Lim Luck Peng and operating under the All Eights Group umbrella. The company serves clinical laboratories, hospitals, healthcare institutions, educational facilities, and research centers across Singapore, Malaysia, and Indonesia with a portfolio spanning rapid point-of-care tests (OSOM Trichomonas, OSOM Ultra Plus Flu A&B, HCV Rapid Test, Syphilis Rapid Test, Strep A Rapid Test), automated laboratory analysers (Diesse Cube 30 Touch), self-sampling devices (Rovers Evalyn Brush), and broader laboratory diagnostic systems from 40+ international manufacturers including Stago, Seegene, Fujirebio, Tosoh Bioscience, Hologic, Meridian Bioscience, Aidian, LGC Maine Standards, Diesse, Sekisui-Veredus, and Hangzhou AllTest.
The business model is classic medical device distribution combined with value-added services: All Eights purchases products from international manufacturers and resells them to end users, earning margins on product sales and fees on bundled technical support (instrument installation, application specialist support, field service engineering, and 24/7 issue resolution). Go-to-market combines a field sales force that runs technical presentations, evaluations, and proof-of-concept projects at hospitals and laboratories with direct-contact channels (website enquiry form, email, phone, WhatsApp) for product enquiries. The company holds GDPMDS certification (since 2009), bizSAFE Level 3 (since 2014), and a medical device importer's licence, enabling it to register, import, and distribute regulated devices across three Southeast Asian markets. Pricing is not publicly disclosed.
All Eights operates a multi-entity corporate structure: the Singapore parent (registration 198302133G) and All Eights (Malaysia) Sdn Bhd anchor the core clinical diagnostics business; Beacon Sciences Pte Ltd was established in 2022 as a wholly-owned spin-off serving the Analytical Science segment and positioned as an international expansion vehicle; and PT Daya Suar Scientific was formed in 2024 as a joint venture to enter Indonesia. The company is privately held by its founder with no external funding rounds, institutional investors, or public listing disclosed.
All Eights firmographics
Firmographics- Name
- All Eights
- Legal name
- All Eights (Singapore) Pte Ltd
- Website
- https://alleights.com
- Company type
- Private
- Founded year
- 1983
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- All Eights is a Singapore-headquartered distributor of in-vitro clinical diagnostic, analytical science, and laboratory equipment products, serving clinical laboratories, hospitals, and research centers across Singapore, Malaysia, and Indonesia through 40+ international brand partnerships since 1983.
- Ownership category
- akta.pro rank
All Eights industry classification
Industry- Product category
- Clinical Diagnostics Distribution
- NAICS
- Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE)
Keywords
Where All Eights is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Offices3 records
Markets served
All Eights business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Product Distribution: All Eights generates revenue as a distributor of clinical diagnostic products, purchasing products from manufacturers and reselling to healthcare institutions, laboratories, and research facilities in Singapore, Malaysia, and Indonesia. Revenue is earned through margins on product sales.
- Technical Support Services: Provides technical support including instrument installation, maintenance, and issue resolution as part of their distribution services, which may be included as part of the product value proposition or charged separately.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
All Eights product offering
Product offeringCore offering
All Eights distributes in-vitro clinical diagnostic and research products and systems on behalf of more than 40 international manufacturers to healthcare institutions, clinical laboratories, research centers, and educational facilities across Singapore, Malaysia, and Indonesia. The offering is end-to-end, combining product distribution with regulatory registration, sales and marketing, logistics, and technical service (Application Specialists and Field Service Engineers). Its subsidiary Beacon Sciences extends the same model into the Analytical Science segment, covering biomolecular processing, food safety, agriculture analysis, industrial microbiology, and life science research.
Product overview
All Eights is a specialist distributor of clinical diagnostic products and laboratory equipment, founded in 1983 and operating across Singapore, Malaysia, and Indonesia. Its product portfolio spans rapid point-of-care tests (OSOM Trichomonas Test, OSOM Ultra Plus Flu A&B Test, HCV Rapid Test, Syphilis Rapid Test, Strep A Rapid Test), automated laboratory analysers (Diesse Cube 30 Touch), and self-sampling devices (Evalyn Brush). The company also represents a broad range of laboratory diagnostic brands including Stago, Seegene, Fujirebio, Tosoh Bioscience, Meridian Bioscience, Hologic, Biocartis, MGI Tech, and Beacon Sciences (a subsidiary for analytical science and scientific equipment). These products are supported through a suite of services encompassing regulatory and product registration, sales and marketing, logistics and customer support, and technical support including application specialists and field service engineers.
Differentiator
Problem solved
Functional benefit
Products and services
- OSOM Trichomonas Test A rapid CLIA-waived test for the detection of Trichomonas vaginalis antigen, delivering objective two-colour results in 10 minutes with 96% sensitivity and 95% specificity. Distributed in Southeast Asia from manufacturer Sekisui-Veredus.
- OSOM Ultra Plus Flu A&B Test An in-vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens from nasal swab and nasopharyngeal swab specimens, delivering differentiated results in 10 minutes via a CLIA-waived procedure. Distributed from manufacturer Sekisui-Veredus.
- Diesse Cube 30 Touch An automated analyzer for erythrocyte sedimentation rate (ESR) that assesses whole blood directly from EDTA tubes, processing up to 30 samples per batch with results in under 25 minutes, equipped with a touchscreen interface, bar-code reader, and internal mixing function. Distributed from manufacturer Diesse Diagnostica.
- HCV Rapid Test A rapid qualitative test for the detection of antibodies to Hepatitis C Virus (HCV), delivering results in 10 minutes with high accuracy and simple visual interpretation. Manufactured by Hangzhou AllTest.
- Syphilis Rapid Test A chromatographic immunoassay cassette test for the qualitative detection of IgG and IgM antibodies to Treponema Pallidum, delivering results in 5 minutes from whole blood, serum, or plasma specimens; CE certified and manufactured by Hangzhou AllTest.
- Strep A Rapid Test A qualitative test for the detection of Group A Streptococcus antigen from throat swab specimens, delivering easy-to-read two-color results in 5 minutes with 96% sensitivity and 98% specificity versus culture; US FDA-cleared and HSA-registered, manufactured by OSOM under Sekisui Diagnostics.
- Evalyn Brush A self-sampling device for Human Papillomavirus (HPV) screening that enables women to collect cervical cancer screening samples at home with flexible bristle technology; sterilised individually packed units with RFID chip support, validated and selected by Dutch and Danish national screening programs, manufactured by Rovers.
Quantifiable outcome
- Over 40 years of continuous operation in Southeast Asian diagnostic markets
- +2 more outcomes
Companies that use All Eights
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
All Eights technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
All Eights partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and standard.
- Stago Diagnostica S.A.ScoreLong-term partnership with Stago Diagnostica, a leading manufacturer in hemostasis diagnostics. All Eights has distributed Stago products since the 1990s and placed their first instrument (Stago STA Compact) in 1998, followed by STA-R for total lab automation in 2003.
- SeegenecoreStrategic partnership for molecular diagnostics. Seegene RV Multiplex was adopted in key accounts in 2008, marking a molecular diagnostic segment milestone for All Eights.
- LGC Maine StandardsstandardDistribution partner for clinical diagnostics quality control products, part of LGC Clinical Diagnostics
- FujirebiocoreLong-term partnership with Fujirebio, a Japan-based in-vitro diagnostics company. Fujirebio was among the successful manual kit brands in the 1990s alongside Omega and Panbio.
- Tosoh BiosciencestandardDistribution partner for clinical diagnostics products from Tosoh Bioscience, serving the bioscience and clinical diagnostics markets.
- Aidian OystandardDistribution partner for Aidian diagnostic products, serving the clinical diagnostics market.
- Diesse DiagnosticacoreDistribution partner for Diesse products including the Diesse Cube 30 Touch automated ESR analyser, an automated analyser for erythrocyte sedimentation rate testing.
- Sekisui-VereduscoreDistribution partner for Sekisui-Veredus products including the OSOM rapid test series (OSOM Trichomonas Test, OSOM Ultra Plus Flu A&B Test, OSOM Strep A Test).
- RoverscoreDistribution partner for Rovers medical devices including the Evalyn Brush, a self-sampling device for HPV screening used in Dutch and Danish screening programs.
- Hangzhou AllTeststandardDistribution partner for AllTest rapid diagnostics including HCV Rapid Test, Syphilis Rapid Test, and other rapid test products.
- HologiccorePlaced 4 Hologic Panther instruments during the COVID-19 outbreak in 2020, with technical team supporting 24/7 operations.
- PT Daya Suar ScientificcoreJoint venture partner for entry into Indonesian market in 2024, established as PT Daya Suar Scientific.
- Beacon SciencescoreEstablished in 2022 as a spin-off company for the distribution of laboratory equipment and scientific products. Serves the Analytical Science segment and serves as a vehicle for international expansion.
Scale indicators4 records
Recent moves8 records
Expansion highlights4 records
All Eights competitors and assessment
Company assessmentEmerging players
- R-Biopharm: German IVD manufacturer distributing clinical diagnostics and food safety test kits through regional partners in Asia. Comparable to All Eights as a multi-brand IVD channel participant targeting clinical and analytical laboratories, though it operates from a manufacturer perspective.
Direct peers
- Pacific Diagnostics: Regional distributor of clinical diagnostics, laboratory reagents and medical devices across Southeast Asia. Closely comparable to All Eights in being a regional multi-brand IVD and lab product distributor serving hospitals and clinical laboratories in overlapping geographies.
- Mega Lifesciences: Thailand-headquartered distributor of pharmaceuticals, medical devices, diagnostics and consumer health products across emerging Southeast Asia. Comparable to All Eights as a regional multi-brand healthcare distributor serving similar hospital, clinic and laboratory customers.
- Bio-Rad Laboratories: Global life science and clinical diagnostics company that distributes IVD reagents, quality controls and instruments through regional partner networks in Asia. Comparable to All Eights as a multi-brand IVD and lab product distributor with regional channel presence.
- Sysmex Asia Pacific: Regional subsidiary of Sysmex Corporation distributing hematology, IVD and clinical chemistry products across Southeast Asia. Closely comparable to All Eights in business model as an IVD-focused distributor serving hospital and laboratory customers in the same geographies.
Broad incumbents
- Zuellig Pharma: One of the largest healthcare distribution groups in Asia, covering pharmaceuticals, medical devices and consumer health across Southeast Asia. While more pharma-focused than All Eights, it competes for the same healthcare distribution contracts and manufacturer partnerships in the region.
- Siemens Healthineers: Large diagnostics and medical imaging vendor with significant direct presence across Southeast Asia in clinical chemistry, immunoassays and hematology. Competes with All Eights for IVD placements in hospitals and reference laboratories across the same regional footprint.
- Thermo Fisher Scientific: Global life sciences and diagnostics company with direct distribution of IVD and laboratory products across Asia Pacific. Comparable to All Eights in its distribution and service of analytical science, life science research and clinical diagnostics products in the same end markets.
- Roche Diagnostics Asia Pacific: Global IVD manufacturer with extensive direct distribution across Southeast Asia, including clinical chemistry, immunoassays and molecular diagnostics. Competes for the same hospital and laboratory end customers as All Eights but operates its own regional sales, service and regulatory infrastructure.
- Abbott Diagnostics: Major IVD manufacturer with direct distribution and partnerships across Asia Pacific in immunoassays, clinical chemistry, hematology and rapid diagnostics. Overlaps with All Eights' clinical diagnostics portfolio and competes for the same hospital and laboratory customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
All Eights social profiles
Digital presenceAll Eights compliance and trust
Trust signalCompliance2 records
All Eights financial estimates
Financial estimateRevenue estimate
Valuation estimate
All Eights leadership team
Management profileNumber of profiles
Profiles1 record
All Eights subsidiaries and ownership
Company hierarchySubsidiaries3 records
All Eights funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
All Eights M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about All Eights
What does All Eights do?
All Eights distributes in-vitro clinical diagnostic and research products and systems on behalf of more than 40 international manufacturers to healthcare institutions, clinical laboratories, research centers, and educational facilities across Singapore, Malaysia, and Indonesia. The offering is end-to-end, combining product distribution with regulatory registration, sales and marketing, logistics, and technical service (Application Specialists and Field Service Engineers). Its subsidiary Beacon Sciences extends the same model into the Analytical Science segment, covering biomolecular processing, food safety, agriculture analysis, industrial microbiology, and life science research.
Is All Eights a public or private company?
All Eights is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was All Eights founded?
All Eights was founded in 1983. It employs 11 to 50 people.
Where is All Eights based?
All Eights is headquartered in Singapore, Singapore, in the Asia region.
How does All Eights make money?
Two revenue lines are on record. Product Distribution is the primary driver. The others are technical Support Services.
Who are All Eights's main competitors?
R-Biopharm is listed as an emerging player. Direct peers are Pacific Diagnostics, Mega Lifesciences, Bio-Rad Laboratories and Sysmex Asia Pacific. Broad incumbents are Zuellig Pharma, Siemens Healthineers, Thermo Fisher Scientific, Roche Diagnostics Asia Pacific and Abbott Diagnostics.
Does All Eights have an API?
No public API is recorded for All Eights.
What industry is All Eights in?
All Eights's product category is Clinical Diagnostics Distribution. Its primary akta.pro industry code is CRAOAHAE, Medical Supplies & Consumables Wholesale (Non-Device). Its NAICS code is 423450 and its SIC code is 5047.